CRISPR Therapeutics (CRSP)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	237.19 mm	237.19 mm	237.19 mm	237.19 mm	237.19 mm	237.19 mm
Cash burn (monthly)	86.27 mm	25.20 mm	36.71 mm	26.03 mm	35.64 mm	15.73 mm
Cash used (since last report)	353.90 mm	103.38 mm	150.60 mm	106.80 mm	146.20 mm	64.55 mm
Cash remaining	-116.71 mm	133.81 mm	86.59 mm	130.39 mm	90.99 mm	172.64 mm
Runway (months of cash)	-1.4	5.3	2.4	5.0	2.6	11.0

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

CRSP institutional ownership history Ownership history

87.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	416	453	-8.2%
Opened positions	44	65	-32.3%
Closed positions	81	88	-8.0%
Increased positions	127	148	-14.2%
Reduced positions	127	121	+5.0%

13F shares	Current	Prev Q	Change
Total value	2.54 tn	2.91 tn	-12.5%
Total shares	74.52 mm	74.64 mm	-0.2%
Total puts	1.90 mm	1.84 mm	+3.3%
Total calls	1.10 mm	1.73 mm	-36.2%
Total put/call ratio	1.7	1.1	+61.9%

Largest owners	Shares	Value	Change
Capital International Investors	7.93 mm	$372.40 bn	+0.8%
ARK Investment Management	7.50 mm	$352.29 bn	-3.6%
VRTX Vertex Pharmaceuticals	5.38 mm	$353.37 mm	0.0%
GSK GSK	3.31 mm	$278.46 mm	0.0%
STT State Street	2.99 mm	$140.61 bn	+25.0%
CMTDF Sumitomo Mitsui Trust	2.97 mm	$139.44 bn	-5.8%
Nikko Asset Management Americas	2.97 mm	$139.37 bn	-5.8%
Bayer Global Investments B.V.	2.95 mm	$154.89 mm	0.0%
BlackRock	2.80 mm	$131.32 bn	NEW
T. Rowe Price Investment Management	2.74 mm	$128.61 mm	+0.2%

Largest transactions	Shares	Bought/sold	Change
BlackRock	2.80 mm	+2.80 mm	NEW
BLK BlackRock	0.00	-2.78 mm	EXIT
Baker Bros. Advisors	843.08 k	+743.08 k	+743.1%
Norges Bank	0.00	-650.21 k	EXIT
STT State Street	2.99 mm	+599.30 k	+25.0%
Balyasny Asset Management	623.65 k	+532.99 k	+587.9%
Farallon Capital Management	0.00	-530.00 k	EXIT
T. Rowe Price	23.76 k	-396.93 k	-94.4%
Citadel Advisors	518.55 k	+375.99 k	+263.7%
ARK Investment Management	7.50 mm	-279.91 k	-3.6%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

CRSP insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
24 Dec 24	Samarth Kulkarni	Common Shares	Option exercise	Acquire M	No	No	16.21	13,751	222.90 k	195,291
24 Dec 24	Samarth Kulkarni	Stock Option Common Shares	Option exercise	Dispose M	No	No	16.21	13,751	222.90 k	0
2 Dec 24	Samarth Kulkarni	Common Shares	Sell	Dispose S	No	Yes	55.1043	15,000	826.56 k	181,540
11 Nov 24	Samarth Kulkarni	Common Shares	Sell	Dispose S	No	Yes	56.27	6,879	387.08 k	196,540
11 Nov 24	Samarth Kulkarni	Common Shares	Sell	Dispose S	No	Yes	55.43	23,121	1.28 mm	203,419
16 Oct 24	Kasinger James R.	RSU Common Shares	Grant	Acquire A	No	No	0	30,000	0.00	30,000
16 Oct 24	Kasinger James R.	Stock Option Common Shares	Grant	Acquire A	No	No	49	18,333	898.32 k	18,333
16 Oct 24	Julianne Bruno	Stock Option Common Shares	Grant	Acquire A	No	No	49	18,333	898.32 k	18,333